About: Lower respiratory tract infections in cats Reaching beyond empirical therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lower respiratory tract infections in cats Reaching beyond empirical therapy Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Lower respiratory tract infections in cats Reaching beyond empirical therapy
Source	Elsevier; Medline; PMC
abstract	Practical relevance Lower respiratory tract infections (LRTIs) in cats can be due to bacteria, parasites, fungi and viruses. This review details the practical investigation of these infections and highlights specific therapy where possible. The aim is to avoid the all-too-frequent temptation in practice to treat cats with lower respiratory tract signs empirically for feline bronchial disease (FBD)/asthma. This is potentially hazardous as immunosuppressive therapy for FBD/asthma could exacerbate disease due to a LRTI. Empirical treatment of suspected LRTI is also difficult to recommend given the wide range of potential pathogens. Clinical challenges Making a clinical ante-mortem diagnosis of LRTI in a cat can be challenging. Consistent historical, clinical, haematological and radiographic abnormalities are often lacking and findings may be non-specific. Astute clinical acumen, thorough investigation and high quality laboratory analysis are usually required for a diagnosis. Bronchoalveolar lavage, if feasible, and tests for lungworm should be routine in cats with lower respiratory tract signs. Lung fine needle aspiration may be useful in cases of diffuse or nodular pulmonary disease. Histopathology is rarely employed in ante-mortem investigations. Evidence base The authors have reviewed a substantial body of literature to provide information on many of the reported bacterial, parasitic, fungal and viral pathogens, including some that occur in Asia. Attention has been given to specific therapy for each pathogen, with evidence-based comments when there is a deviation from routine recommendations.
has issue date	2011-05-31(xsd:dateTime)
bibo:doi	10.1016/j.jfms.2011.03.009
bibo:pmid	21515220
has license	els-covid
sha1sum (hex)	20e2c8b0a3aaa8982db26b6200a0d8a80a211db2
schema:url	https://doi.org/10.1016/j.jfms.2011.03.009
resource representing a document's title	Lower respiratory tract infections in cats Reaching beyond empirical therapy
has PubMed Central identifier	PMC7129729
has PubMed identifier	21515220
schema:publication	Journal of Feline Medicine & Surgery
resource representing a document's body	covid:20e2c8b0a3aaa8982db26b6200a0d8a80a211db2#body_text
is schema:about of	named entity 'CLINICAL DIAGNOSIS' named entity 'PREREQUISITES' named entity 'FELINE' named entity 'LRTI' named entity 'LRTI' named entity 'biopsies' named entity 'Clindamycin' named entity 'interstitial pneumonia' named entity 'parasites' named entity 'infection' named entity 'China' named entity 'pneumonia' named entity 'pneumonia' named entity 'dyspnoea' named entity 'necrotising' named entity 'lower respiratory tract' named entity 'fine needle aspiration' named entity 'clindamycin' named entity 'polymerase chain reaction' named entity 'pulmonary arteries' named entity 'LRTI' named entity 'theophylline' named entity 'clindamycin' named entity 'LRTI' named entity 'bacteria' named entity 'Paragonimus kellicotti' named entity 'chloramphenicol' named entity 'white cell' named entity 'triazines' named entity 'Anaesthetise' named entity 'mycoplasmas' named entity 'clindamycin' named entity 'macrophages' named entity 'toltrazuril' named entity 'pulmonary haemorrhage' named entity 'Bayer' named entity 'FIV' named entity 'histopathology' named entity 'imidocarb' named entity 'capillariasis' named entity 'Siamese cats' named entity 'LRTI' named entity 'bronchus' named entity 'mycobacteria' named entity 'cytology' named entity 'enteric bacteria' named entity 'β-lactam' named entity 'antigen' named entity 'parenteral' named entity 'antibiotic' named entity 'cytopathology' named entity 'URT' named entity 'microbiology' named entity 'erythromycin' named entity 'Gentamicin' named entity 'parasitology' named entity 'clindamycin' named entity 'fine needle aspiration' named entity 'Mycoplasma' named entity 'pneumonia' named entity 'erythromycin' named entity 'radiographic' named entity 'chlamydial' named entity 'fine needle aspiration' named entity 'hepatitis' named entity 'catheter' named entity 'empirical treatment' named entity 'parasitic infections' named entity 'Bordetella bronchiseptica' named entity 'Lancefield' named entity 'doxycycline' named entity 'LRTI' named entity 'sneezing' named entity 'H1N1' named entity 'terbutaline' named entity 'LRTI' named entity 'tachypnoea' named entity 'antibiotic' named entity 'cryptococcosis' named entity 'pathogens' named entity 'doxycycline' named entity 'haemoptysis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software